| 1. |
李響, 李恒希, 鄭榮壽, 等. 2024全球癌癥統計數據解讀: 中國與全球對比 [J]. 中國普外基礎與臨床雜志, 2026, 33(8): 1009-1017.
|
| 2. |
Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020 [J]. Chin Med J (Engl), 2021, 134(7): 783-791.
|
| 3. |
Gu MJ, Huang QC, Bao CZ, et al. Attributable causes of colorectal cancer in China [J/OL]. BMC Cancer, 2018, 18(1): 38. doi: 10.1186/s12885-017-3968-z.
|
| 4. |
Li N, Lu B, Luo C, et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: a comparison among China, Europe, and northern America [J]. Cancer Lett, 2021, 522: 255-268.
|
| 5. |
Matsuda T, Fujimoto A, Igarashi Y. Colorectal cancer: epidemiology, risk factors, and public health strategies [J]. Digestion, 2025, 106(2): 91-99.
|
| 6. |
Yang Y, Han Z, Li X, et al. Epidemiology and risk factors of colorectal cancer in China [J]. Chin J Cancer Res, 2020, 32(6): 729-741.
|
| 7. |
Yin Y, Zhang X. Analysis of trends in the burden of colorectal cancer in China and globally from 1990 to 2021 with projections for the next 15 years: a cross-sectional study based on the GBD database [J/OL]. Front Public Health, 2025, 13: 1518536. doi: 10.3389/fpubh.2025.1518536.
|
| 8. |
Global Burden of Disease 2019 Cancer Collaboration. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019 [J]. JAMA Oncol, 2022, 8(3): 420-444.
|
| 9. |
Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020 [J]. Cancer Commun (Lond), 2021, 41(10): 1037-1048.
|
| 10. |
Murray CJL. The global burden of disease study at 30 years [J]. Nat Med, 2022, 28(10): 2019-2026.
|
| 11. |
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021 [J]. Lancet, 2024, 403(10440): 2133-2161.
|
| 12. |
Wang X, Xiu R, Gong L, et al. Unraveling the global burden of inflammatory bowel disease (1990-2019): a joinpoint regression analysis of divergent trends in 10-24 and 50-69 age cohorts [J/OL]. Autoimmun Rev, 2024, 23(6): 103586. doi: 10.1016/j.autrev.2024.103586.
|
| 13. |
Kim HJ, Chen HS, Byrne J, et al. Twenty years since joinpoint 1.0: two major enhancements, their justification, and impact [J]. Stat Med, 2022, 41(16): 3102-3130.
|
| 14. |
Cayuela L, Gaeta AM, Lopez-Campos JL, et al. Age-period-cohort effect on lung cancer mortality in Spain, 1982-2021 [J]. Lung Cancer, 2023, 178: 269-276.
|
| 15. |
Tozduman B, Emecen AN. Age period cohort analysis of cancer incidence from 1990 to 2019 in Türkiye [J/OL]. Cancer Epidemiol, 2025, 96: 102803. doi: 10.1016/j.canep.2025.102803.
|
| 16. |
王曉琪, 周澤玫, 許俠, 等. 2005-2023年中國流行性腮腺炎發病趨勢的Joinpoint回歸模型和年齡-時期-隊列模型分析 [J]. 中國疫苗和免疫, 2024, 30(6): 642-646.
|
| 17. |
李梓菡, 彭鵬, 趙文嘉, 等. 2014—2023年濰坊市日均氣溫與水痘發病關系: 基于分布滯后非線性模型分析 [J]. 醫學新知, 2026, 36(2): 132-137.
|
| 18. |
王瑋, 楊洋, 曹亞玲. 基于分布滯后非線性模型分析日均氣溫對張掖市慢性阻塞性肺部疾病發病的影響 [J]. 甘肅醫藥, 2025, 44(1): 33-37.
|
| 19. |
Wang Z, Dan W, Zhang N, et al. Colorectal cancer and gut microbiota studies in China [J/OL]. Gut Microbes, 2023, 15(1): 2236364. doi: 10.1080/19490976.2023.2236364.
|
| 20. |
Li J, Yao H, Lu Y, et al. Chinese national clinical practice guidelines on prevention, diagnosis and treatment of early colorectal cancer [J]. Chin Med J (Engl), 2024, 137(17): 2017-2039.
|
| 21. |
Kadakuntla A, Wang T, Medgyesy K, et al. Colorectal cancer screening in the COVID-19 era [J]. World J Gastrointest Oncol, 2021, 13(4): 238-251.
|
| 22. |
Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality [J]. Gut, 2017, 66(4): 683-691.
|
| 23. |
Tsukanov VV, Vasyutin AV, Tonkikh JL. Risk factors, prevention and screening of colorectal cancer: a rising problem [J/OL]. World J Gastroenterol, 2025, 31(5): 98629. doi: 10.3748/wjg.v31.i5.98629.
|
| 24. |
Conti L, Del Cornò M, Gessani S. Revisiting the impact of lifestyle on colorectal cancer risk in a gender perspective [J/OL]. Crit Rev Oncol Hematol, 2020, 145: 102834. doi. doi: 10.1016/j.critrevonc.2019.102834.
|
| 25. |
Zhang Y, Zhang X, Ding Y, et al. Distinct time trends in colorectal cancer incidence in countries with SDI levels from 1990 to 2019: an age-period-cohort analysis for the global burden of disease 2019 study [J/OL]. Front Public Health, 2024, 12: 1370282. doi: 10.3389/fpubh.2024.1370282.
|
| 26. |
Morgan E, Arnold M, Gini A, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN [J]. Gut, 2023, 72(2): 338-344.
|
| 27. |
Andrew AS, Parker S, Anderson JC, et al. Risk factors for diagnosis of colorectal cancer at a late stage: a population-based study [J]. J Gen Intern Med, 2018, 33(12): 2100-2105.
|